MAQTOX is collaborating with Telomir Pharmaceuticals to investigate the effects of Telomir-1 on telomere lengthening and its potential to treat age-related diseases. This research aims to explore how Telomir-1 can extend telomeres in human cells, particularly focusing on cell lines like MRC-5 fetal lung fibroblasts, HUVEC, and mesenchymal stem cells. The project also involves pre-clinical studies and data analysis to assess the safety and efficacy of Telomir-1 in addressing conditions linked to aging and inflammatory processes.
The key outcomes of this project will include:
The project’s success could redefine the possibilities for extending healthy human lifespan and reversing age-associated diseases.